Projects

doc. RNDr. Tatiana Betáková, DrSc.

International

Finished
  • CAPSID - Scientific capacity building in biomedical research through scientific exchange and co-development of research services
    Program: European Regional Development Fund (ERDF)
    Duration: 1. 7. 2018 – 30. 6. 2021

National

Current
  • The immune cell subsets and apoptosis in response to influenza A virus
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
Finished
  • Influence of NS1 protein and influenza virus load on the pathogenesis and innate immune response in brains, hearts and spleens of infected mice
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Isolation, identification and characterization of transforming growth factor-beta 1 binding molecule(s) in tick salivary gland extracts.
    Program: VEGA
    Duration: 1. 1. 2019 – 31. 12. 2022
  • The role of cytokines/chemokines in the immune response to influenza A infection
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Characterization of novel motif in M1 protein of influenza A virus and using NS1 deletion mutants in tumor therapy
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • Murine gammaherpesvirus a producent of substances exhibiting immunomodulatory and antiproliferative properties
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • -
    Program: EU Structural Funds Research & Development
    Duration: 1. 3. 2014 – 31. 12. 2015
  • Therapeutic potential of RNA interference and interferons against influenza virus infection
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • Antiviral activities of interferons lambda (type III) against some medical important viruses
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Diagnostics of socially important disorders in Slovakia, based on modern biotechnologies
    Program: EU Structural Funds Research & Development
    Duration: 2. 11. 2010 – 31. 10. 2013
  • Diagnoses of Socially Important Diseases in Slovakia Based on Modern Biotechnologies.
    Program: EU Structural Funds Research & Development
    Duration: 1. 11. 2010 – 31. 10. 2013
  • New cultivation substrates research for preparation of vaccines
    Program: Other projects
    Duration: 16. 12. 2009 – 16. 10. 2012
  • Centre of Excellence for Translational Research in Molecular medicine
    Program: EU Structural Funds Research & Development
    Duration: 1. 6. 2010 – 31. 5. 2012
  • Construction of small interfering RNA (siRNA) against influenza viruses
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Center of Excelence for Translational Research in Molecular Medicine
    Program: EU Structural Funds Research & Development
    Duration: 1. 6. 2009 – 31. 5. 2011
  • Ecology and geographic distribution of virus pathogens (influenza A) and bacteria (borrelia, mycobacteria, and chlamydophila) in wild birds in Slovakia
    Program: VEGA
    Duration: 1. 1. 2008 – 31. 12. 2010
  • Surveillance of influenza virus in Slovakia, studying the pH activity of the M2 proton channel by mutagenesis, and searching for new anti-viral agents
    Program: SRDA
    Duration: 1. 3. 2006 – 30. 10. 2009
  • Influence of C-domain of the M2 proton channel of influenza a virus on pH activity and its role in the virus replication , pipeline for new antiviral agents - M2 inhibitors and siRNAs.
    Program: VEGA
    Duration: 1. 1. 2006 – 31. 12. 2008
  • Monitoring and diagnosing of influenza viruses with pandemic potential and education of specialists
    Program:
    Duration: 1. 9. 2005 – 31. 8. 2008
Employees